BofA lowered the firm’s price target on ZoomInfo to $20 from $23 and keeps a Neutral rating on the shares. The firm, which cites both lower 2024/25 revenue estimates and a lower multiple to account for its target cut, believes the muted Q4 outlook and cautious demand commentary for the first half of 2024 will keep shares range-bound until there are concrete data points that end-market demand has stabilized.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ZI:
